Lloyd Segal
Fortune : 508 639 $ au 31/08/2026
Fortune : 508 639 $ au 31/08/2026
Lloyd M.
Segal was the founder of Repare Therapeutics, Inc., founded in 2016, where the titles held included President, CEO, Secretary & Director from 2016 to 2025.
Mr. Segal is also the founder of Caprion Pharmaceuticals, Inc...
Mr. Segal currently serves as Independent Director at Aktis Oncology, Inc. since 2021, Director at Therapure Biopharma, Inc. since 2016, and Director at American Funds Growth Fund of America.
Former positions include Chief Executive Officer at Advanced Bioconcept Ltd., Chief Executive Officer at Thallion Pharmaceuticals, Inc. from 2007 to 2010, Chairman at LMC Diabetes & Endocrinology Ltd., Chairman at MedReleaf Corp., Director at Pembroke American Growth Fund Inc, Director at Biovail Corp., Independent Director at Diagnos, Inc. from 2014 to 2015, Independent Director at Bausch Health Cos., Inc. from 2012 to 2014, Managing Partner at Persistence Capital Partners LP from 2010 to 2016, Managing Partner at PCP Management, Inc., Management Consultant at McKinsey & Co., Inc. (Canada), and Entrepreneur in Residence at Versant Ventures Canada Ltd. from 2017 to 2020.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. 0,04% | 12/01/2026 | 19 631 ( 0,04% ) | 508 639 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/02/2021 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | 08/02/2016 |
American Funds Growth Fund of America
American Funds Growth Fund of America Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Directeur/Membre du Conseil | 15/09/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Fondateur | 11/04/2025 |
Versant Ventures Canada Ltd.
Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/03/2020 |
Persistence Capital Partners LP
Persistence Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund | Corporate Officer/Principal | 01/01/2016 |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | 07/06/2011 |
Advanced Bioconcept Ltd.
Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Makes proprietary, fluorescent labeled peptids | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 19 |
|---|---|
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Diagnos, Inc.
Diagnos, Inc. Information Technology ServicesTechnology Services Provides artificial intelligence services in healthcare sector | Technology Services |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Health Technology |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
American Funds Growth Fund of America
American Funds Growth Fund of America Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Pembroke American Growth Fund Inc
Pembroke American Growth Fund Inc Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Advanced Bioconcept Ltd.
Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Makes proprietary, fluorescent labeled peptids | Electronic Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thallion Pharmaceuticals, Inc.
Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products | Health Technology |
Persistence Capital Partners LP
Persistence Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
PCP Management, Inc.
PCP Management, Inc. Investment ManagersFinance PCP invests in companies located in Canada with an EBITDA of CAD 1 - 15 million. The firm focus on the healthcare sector. It provides financing for buyout, recapitalization, MBOs, divestitures/carve-outs, distressed restructuring and growth capital requirements. The firm also makes co-investments. | Finance |
Bausch Health Cos., Inc.
Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
McKinsey & Co., Inc. (Canada)
McKinsey & Co., Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
LMC Diabetes & Endocrinology Ltd.
LMC Diabetes & Endocrinology Ltd. Medical/Nursing ServicesHealth Services Provides mental health, optometry and foot care services | Health Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Ventures Canada Ltd.
Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
MedReleaf Corp.
MedReleaf Corp. Industrial ConglomeratesProducer Manufacturing Produces and distributes medical cannabis | Producer Manufacturing |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapies | Health Technology |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national